Peripheral Arterial Disease Trial, Recruiting NCT06951685 Sponsor: Xeltis Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT06951685
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have a blocked femoral artery in your leg and need planned surgery to reroute blood flow above the knee (called a femoral popliteal bypass)
  • Your leg circulation problem has been rated at a specific level of severity (Rutherford grade 3, 4, or 5), and your blockage is classified as a more complex type (TASC C or D lesion)
  • If you have a grade 5 rating, you may still be eligible if you have a wound or foot infection of limited severity, and at least two blood vessels are still open in the lower leg reaching the foot (confirm with trial site)
  • You are at least 18 years old
  • Your blood vessels have been assessed as having suitable anatomy, confirmed by a CT scan with contrast dye or an angiogram taken within the last 90 days
  • You are willing to give written consent after being fully informed about the study
  • You agree to attend all required check-ups before and after the procedure, including follow-up imaging
  • You are expected to live for at least 24 months

Who may not be able to join:

  • You need or are scheduled for heart surgery or a different blood vessel surgery within 30 days of this procedure
  • You have had a previous bypass surgery in the affected leg
  • You need multiple procedures to restore blood flow in the same limb, or other procedures requiring additional vascular grafts
  • You have had a stroke or heart attack within the last 6 weeks, or have had a severe stroke in the past that significantly affects your daily function
  • You have a history of a sudden, severe artery blockage that needed emergency treatment
  • You have serious kidney disease (with a specific blood marker above a set level) or are on dialysis
  • You have had a kidney transplant
  • You have very high blood pressure that is not controlled (above 200 mmHg on two separate readings)
  • You have diabetes that is not well controlled
  • You have abnormal blood test results that could affect your recovery or how well the graft works (confirm with trial site)
  • You have reduced liver function shown by specific blood test results being above acceptable levels
  • You have any active infection, either in one part of your body or throughout your whole body
  • You have a condition where heparin (a blood-thinning medication) has caused a dangerous drop in your platelet levels in the past
  • You have an active bleeding disorder, a blood clotting problem, or a condition where blood clots form abnormally
  • You have known allergies to the device material (a metal called nitinol), contrast dye used in imaging, or aspirin, that cannot be managed with medication
  • You have previously taken part in this same study
  • You are currently taking part in another clinical study
  • You are pregnant, breastfeeding, or are able to become pregnant and are not using adequate contraception
  • Your doctor decides there is any other reason that would make it unsafe or unsuitable for you to take part (confirm with trial site)
  • During surgery, if your blood vessels are found to be a different size than expected or too heavily calcified, you may not be able to receive the study device

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +31 40 751 7614

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Xeltis
Registry
ClinicalTrials.gov
Start date
2 May 2025
Est. completion
1 September 2026

Where this trial is recruiting

Costa Rica

Primary endpoints

Primary patency rate; Freedom from device-related SAE

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov